메뉴 건너뛰기




Volumn 5, Issue 11, 2013, Pages 793-801

Immunostimulatory activity of lifespan-extending agents

Author keywords

ATG5; Everolimus; mTOR; Sirolimus; Tacrolimus; Temsirolimus

Indexed keywords

IMMUNOLOGIC FACTOR; RAPAMYCIN;

EID: 84891528948     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100619     Document Type: Review
Times cited : (25)

References (108)
  • 8
    • 84861085191 scopus 로고    scopus 로고
    • Autophagy mediates the metabolic benefits of endurance training
    • Galluzzi L and Kroemer G. Autophagy mediates the metabolic benefits of endurance training. Circulation research. 2012; 110:1276-1278.
    • (2012) Circulation research , vol.110 , pp. 1276-1278
    • Galluzzi, L.1    Kroemer, G.2
  • 9
    • 77953624320 scopus 로고    scopus 로고
    • Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR
    • Blagosklonny MV. Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR. Cell death & disease. 2010; 1:e12.
    • (2010) Cell death & disease , vol.1
    • Blagosklonny, M.V.1
  • 17
    • 35448981935 scopus 로고    scopus 로고
    • Autophagy: from phenomenology to molecular understanding in less than a decade
    • Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nature reviews Molecular cell biology. 2007; 8:931-937.
    • (2007) Nature reviews Molecular cell biology , vol.8 , pp. 931-937
    • Klionsky, D.J.1
  • 18
    • 35848937781 scopus 로고    scopus 로고
    • Autophagy is required for dietary restriction-mediated life span extension in C. elegans
    • Jia K and Levine B. Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy. 2007; 3:597-599.
    • (2007) Autophagy , vol.3 , pp. 597-599
    • Jia, K.1    Levine, B.2
  • 20
    • 67650243271 scopus 로고    scopus 로고
    • Autophagy genes mediate the effect of calcineurin on life span in C. elegans
    • Dwivedi M, Song HO and Ahnn J. Autophagy genes mediate the effect of calcineurin on life span in C. elegans. Autophagy. 2009; 5:604-607.
    • (2009) Autophagy , vol.5 , pp. 604-607
    • Dwivedi, M.1    Song, H.O.2    Ahnn, J.3
  • 24
    • 79959354999 scopus 로고    scopus 로고
    • Mitochondria and the autophagy-inflammation-cell death axis in organismal aging
    • Green DR, Galluzzi L and Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011; 333:1109-1112.
    • (2011) Science , vol.333 , pp. 1109-1112
    • Green, D.R.1    Galluzzi, L.2    Kroemer, G.3
  • 26
    • 84861526009 scopus 로고    scopus 로고
    • Deconvoluting the context-dependent role for autophagy in cancer
    • White E. Deconvoluting the context-dependent role for autophagy in cancer. Nature reviews Cancer. 2012; 12:401-410.
    • (2012) Nature reviews Cancer , vol.12 , pp. 401-410
    • White, E.1
  • 27
    • 78649338141 scopus 로고    scopus 로고
    • Autophagy and the integrated stress response
    • Kroemer G, Marino G and Levine B. Autophagy and the integrated stress response. Molecular cell. 2010; 40:280-293.
    • (2010) Molecular cell , vol.40 , pp. 280-293
    • Kroemer, G.1    Marino, G.2    Levine, B.3
  • 28
    • 83755219008 scopus 로고    scopus 로고
    • Hormesis, cell death and aging
    • Martins I, Galluzzi L and Kroemer G. Hormesis, cell death and aging. Aging. 2011; 3:821-828.
    • (2011) Aging , vol.3 , pp. 821-828
    • Martins, I.1    Galluzzi, L.2    Kroemer, G.3
  • 29
    • 78751672975 scopus 로고    scopus 로고
    • Autophagy in immunity and inflammation
    • Levine B, Mizushima N and Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469:323-335.
    • (2011) Nature , vol.469 , pp. 323-335
    • Levine, B.1    Mizushima, N.2    Virgin, H.W.3
  • 30
    • 84879107779 scopus 로고    scopus 로고
    • Intestinal epithelial autophagy is essential for host defense against invasive bacteria
    • Benjamin JL, Sumpter R, Jr., Levine B and Hooper LV. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. Cell host & microbe. 2013; 13:723-734.
    • (2013) Cell host & microbe , vol.13 , pp. 723-734
    • Benjamin, J.L.1    Sumpter Jr, R.2    Levine, B.3    Hooper, L.V.4
  • 32
    • 84882712453 scopus 로고    scopus 로고
    • Autophagy and cellular immune responses
    • Ma Y, Galluzzi L, Zitvogel L and Kroemer G. Autophagy and cellular immune responses. Immunity. 2013; 39:211-227.
    • (2013) Immunity , vol.39 , pp. 211-227
    • Ma, Y.1    Galluzzi, L.2    Zitvogel, L.3    Kroemer, G.4
  • 33
  • 35
    • 84886943831 scopus 로고    scopus 로고
    • A perspective on new immune adjuvant principles: Reprogramming inflammatory states to permit clearance of cancer cells and other age-associated cellular pathologies
    • Prendergast GC and Metz R. A perspective on new immune adjuvant principles: Reprogramming inflammatory states to permit clearance of cancer cells and other age-associated cellular pathologies. Oncoimmunology. 2012; 1:924-929.
    • (2012) Oncoimmunology , vol.1 , pp. 924-929
    • Prendergast, G.C.1    Metz, R.2
  • 36
  • 37
    • 0035166843 scopus 로고    scopus 로고
    • Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation
    • Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -European Renal Association
    • Morelon E, Mamzer-Bruneel MF, Peraldi MN and Kreis H. Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -European Renal Association. 2001; 16:18-20.
    • (2001) , vol.16 , pp. 18-20
    • Morelon, E.1    Mamzer-Bruneel, M.F.2    Peraldi, M.N.3    Kreis, H.4
  • 39
    • 0032573044 scopus 로고    scopus 로고
    • Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
    • Kahan BD, Podbielski J, Napoli KL, Katz SM, Meier-Kriesche HU and Van Buren CT. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation. 1998; 66:1040-1046.
    • (1998) Transplantation , vol.66 , pp. 1040-1046
    • Kahan, B.D.1    Podbielski, J.2    Napoli, K.L.3    Katz, S.M.4    Meier-Kriesche, H.U.5    Van Buren, C.T.6
  • 41
    • 84898003300 scopus 로고    scopus 로고
    • Immunosuppressants in cancer prevention and therapy Oncoimmunology
    • Blagosklonny MV. Immunosuppressants in cancer prevention and therapy Oncoimmunology. 2013; 2:e26961.
    • (2013) , vol.2
    • Blagosklonny, M.V.1
  • 42
    • 4043142865 scopus 로고    scopus 로고
    • Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
    • Mathew T, Kreis H and Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clinical transplantation. 2004; 18:446-449.
    • (2004) Clinical transplantation , vol.18 , pp. 446-449
    • Mathew, T.1    Kreis, H.2    Friend, P.3
  • 43
    • 33645067673 scopus 로고    scopus 로고
    • Individualization of immunosuppressive therapy III. Sirolimus associated with a reduced incidence of malignancy
    • Yakupoglu YK, Buell JF, Woodle S and Kahan BD. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplantation proceedings. 2006; 38:358-361.
    • (2006) Transplantation proceedings , vol.38 , pp. 358-361
    • Yakupoglu, Y.K.1    Buell, J.F.2    Woodle, S.3    Kahan, B.D.4
  • 46
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman HM, Cherikh WS, Cheng Y, Hanto DW and Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005; 80:883-889.
    • (2005) Transplantation , vol.80 , pp. 883-889
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3    Hanto, D.W.4    Kahan, B.D.5
  • 64
    • 84886944522 scopus 로고    scopus 로고
    • EGFR inhibitors MHC expression and immune responses: Can EGFR inhibitors be used as immune response modifiers?
    • Pollack BP. EGFR inhibitors, MHC expression and immune responses: Can EGFR inhibitors be used as immune response modifiers? Oncoimmunology. 2012; 1:71-74.
    • (2012) Oncoimmunology , vol.1 , pp. 71-74
    • Pollack, B.P.1
  • 66
    • 54549089738 scopus 로고    scopus 로고
    • Hypoxia signalling through mTOR and the unfolded protein response in cancer
    • Wouters BG and Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature reviews Cancer. 2008; 8:851-864.
    • (2008) Nature reviews Cancer , vol.8 , pp. 851-864
    • Wouters, B.G.1    Koritzinsky, M.2
  • 67
    • 67749111502 scopus 로고    scopus 로고
    • The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
    • Shackelford DB and Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nature reviews Cancer. 2009; 9:563-575.
    • (2009) Nature reviews Cancer , vol.9 , pp. 563-575
    • Shackelford, D.B.1    Shaw, R.J.2
  • 69
    • 33745013651 scopus 로고    scopus 로고
    • Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages
    • Yang CS, Song CH, Lee JS, Jung SB, Oh JH, Park J, Kim HJ, Park JK, Paik TH and Jo EK. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cellular microbiology. 2006; 8:1158-1171.
    • (2006) Cellular microbiology , vol.8 , pp. 1158-1171
    • Yang, C.S.1    Song, C.H.2    Lee, J.S.3    Jung, S.B.4    Oh, J.H.5    Park, J.6    Kim, H.J.7    Park, J.K.8    Paik, T.H.9    Jo, E.K.10
  • 73
    • 62049084947 scopus 로고    scopus 로고
    • Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
    • Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL, Jr. and Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nature medicine. 2009; 15:267-276.
    • (2009) Nature medicine , vol.15 , pp. 267-276
    • Jagannath, C.1    Lindsey, D.R.2    Dhandayuthapani, S.3    Xu, Y.4    Hunter Jr, R.L.5    Eissa, N.T.6
  • 76
    • 75549090275 scopus 로고    scopus 로고
    • mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells
    • Chen C, Liu Y, Liu Y and Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science signaling. 2009; 2:ra75.
    • (2009) Science signaling , vol.2
    • Chen, C.1    Liu, Y.2    Liu, Y.3    Zheng, P.4
  • 77
    • 84873323853 scopus 로고    scopus 로고
    • The combination of IkappaB kinase beta inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells
    • Nishioka C, Ikezoe T, Yang J, Udaka K and Yokoyama A. The combination of IkappaB kinase beta inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells. Immunology. 2013; 138:216-227.
    • (2013) Immunology , vol.138 , pp. 216-227
    • Nishioka, C.1    Ikezoe, T.2    Yang, J.3    Udaka, K.4    Yokoyama, A.5
  • 79
    • 50949130076 scopus 로고    scopus 로고
    • Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells
    • Ohtani M, Nagai S, Kondo S, Mizuno S, Nakamura K, Tanabe M, Takeuchi T, Matsuda S and Koyasu S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood. 2008; 112:635-643.
    • (2008) Blood , vol.112 , pp. 635-643
    • Ohtani, M.1    Nagai, S.2    Kondo, S.3    Mizuno, S.4    Nakamura, K.5    Tanabe, M.6    Takeuchi, T.7    Matsuda, S.8    Koyasu, S.9
  • 82
    • 0038036797 scopus 로고    scopus 로고
    • Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo
    • Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, Gessner A and Thomson AW. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood. 2003; 101:4457-4463.
    • (2003) Blood , vol.101 , pp. 4457-4463
    • Hackstein, H.1    Taner, T.2    Zahorchak, A.F.3    Morelli, A.E.4    Logar, A.J.5    Gessner, A.6    Thomson, A.W.7
  • 85
    • 74649085700 scopus 로고    scopus 로고
    • The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin
    • Rao RR, Li Q, Odunsi K and Shrikant PA. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity. 2010; 32:67-78.
    • (2010) Immunity , vol.32 , pp. 67-78
    • Rao, R.R.1    Li, Q.2    Odunsi, K.3    Shrikant, P.A.4
  • 86
    • 84886943632 scopus 로고    scopus 로고
    • AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications: Evidence for IL-12 intracrine activity in DC
    • You CX, Shi M, Liu Y, Cao M, Luo R and Hermonat PL. AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications: Evidence for IL-12 intracrine activity in DC. Oncoimmunology. 2012; 1:847-855.
    • (2012) Oncoimmunology , vol.1 , pp. 847-855
    • You, C.X.1    Shi, M.2    Liu, Y.3    Cao, M.4    Luo, R.5    Hermonat, P.L.6
  • 87
    • 84886944747 scopus 로고    scopus 로고
    • Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy
    • Song DG and Powell DJ. Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy. Oncoimmunology. 2012; 1:547-549.
    • (2012) Oncoimmunology , vol.1 , pp. 547-549
    • Song, D.G.1    Powell, D.J.2
  • 88
    • 84859400580 scopus 로고    scopus 로고
    • Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity
    • Li Q, Rao R, Vazzana J, Goedegebuure P, Odunsi K, Gillanders W and Shrikant PA. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity. Journal of immunology. 2012; 188:3080-3087.
    • (2012) Journal of immunology , vol.188 , pp. 3080-3087
    • Li, Q.1    Rao, R.2    Vazzana, J.3    Goedegebuure, P.4    Odunsi, K.5    Gillanders, W.6    Shrikant, P.A.7
  • 89
    • 84877057592 scopus 로고    scopus 로고
    • Rapamycin: A rheostat for CD8(+) T-cell-mediated tumor therapy
    • Srivastava RK, Utley A and Shrikant PA. Rapamycin: A rheostat for CD8(+) T-cell-mediated tumor therapy. Oncoimmunology. 2012; 1:1189-1190.
    • (2012) Oncoimmunology , vol.1 , pp. 1189-1190
    • Srivastava, R.K.1    Utley, A.2    Shrikant, P.A.3
  • 90
    • 79953814668 scopus 로고    scopus 로고
    • Rapamycin increases the yield and effector function of human gammadelta T cells stimulated in vitro
    • Li H and Pauza CD. Rapamycin increases the yield and effector function of human gammadelta T cells stimulated in vitro. Cancer immunology, immunotherapy: CII. 2011; 60:361-370.
    • (2011) Cancer immunology, immunotherapy: CII , vol.60 , pp. 361-370
    • Li, H.1    Pauza, C.D.2
  • 92
    • 84886943865 scopus 로고    scopus 로고
    • Licensing of gammadeltaT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses
    • Anderson J, Gustafsson K, Himoudi N, Yan M and Heuijerjans J. Licensing of gammadeltaT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology. 2012; 1:1652-1654.
    • (2012) Oncoimmunology , vol.1 , pp. 1652-1654
    • Anderson, J.1    Gustafsson, K.2    Himoudi, N.3    Yan, M.4    Heuijerjans, J.5
  • 93
    • 84886944354 scopus 로고    scopus 로고
    • Immunotherapy of acute myeloid leukemia based on gammadelta T cells
    • Gertner-Dardenne J, Fauriat C, Vey N and Olive D. Immunotherapy of acute myeloid leukemia based on gammadelta T cells. Oncoimmunology. 2012; 1:1614-1616.
    • (2012) Oncoimmunology , vol.1 , pp. 1614-1616
    • Gertner-Dardenne, J.1    Fauriat, C.2    Vey, N.3    Olive, D.4
  • 95
    • 84885920743 scopus 로고    scopus 로고
    • Interleukin-15 gene therapy and the mammalian target of rapamycin inhibitor everolimus inhibit the growth of metastatic breast cancer
    • Zhao N, Li X, He X, Qiu Y, Zhu L and Qi F. Interleukin-15 gene therapy and the mammalian target of rapamycin inhibitor everolimus inhibit the growth of metastatic breast cancer. The journal of gene medicine. 2013; 15:366-374.
    • (2013) The journal of gene medicine , vol.15 , pp. 366-374
    • Zhao, N.1    Li, X.2    He, X.3    Qiu, Y.4    Zhu, L.5    Qi, F.6
  • 96
    • 79951670258 scopus 로고    scopus 로고
    • Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines
    • Wang Y, Wang XY, Subjeck JR, Shrikant PA and Kim HL. Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines. British journal of cancer. 2011; 104:643-652.
    • (2011) British journal of cancer , vol.104 , pp. 643-652
    • Wang, Y.1    Wang, X.Y.2    Subjeck, J.R.3    Shrikant, P.A.4    Kim, H.L.5
  • 98
    • 84880688294 scopus 로고    scopus 로고
    • IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
    • Metz R, Rust S, Duhadaway JB, Mautino MR, Munn DH, Vahanian NN, Link CJ and Prendergast GC. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology. 2012; 1:1460-1468.
    • (2012) Oncoimmunology , vol.1 , pp. 1460-1468
    • Metz, R.1    Rust, S.2    Duhadaway, J.B.3    Mautino, M.R.4    Munn, D.H.5    Vahanian, N.N.6    Link, C.J.7    Prendergast, G.C.8
  • 99
    • 77951678634 scopus 로고    scopus 로고
    • The role of mTOR in memory CD8 T-cell differentiation
    • Araki K, Youngblood B and Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunological reviews. 2010; 235:234-243.
    • (2010) Immunological reviews , vol.235 , pp. 234-243
    • Araki, K.1    Youngblood, B.2    Ahmed, R.3
  • 100
    • 84886945201 scopus 로고    scopus 로고
    • Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
    • Hoos A, Janetzki S and Britten CM. Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring. Oncoimmunology. 2012; 1:1457-1459.
    • (2012) Oncoimmunology , vol.1 , pp. 1457-1459
    • Hoos, A.1    Janetzki, S.2    Britten, C.M.3
  • 102
    • 84886747363 scopus 로고    scopus 로고
    • Single lowdose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
    • Malvicini M, Alaniz L, Bayo J, Garcia M, Piccioni F, Fiore E, Atorrasagasti C, Aquino JB, Matar P and Mazzolini G. Single lowdose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice. Oncoimmunology. 2012; 1:1038-1047.
    • (2012) Oncoimmunology , vol.1 , pp. 1038-1047
    • Malvicini, M.1    Alaniz, L.2    Bayo, J.3    Garcia, M.4    Piccioni, F.5    Fiore, E.6    Atorrasagasti, C.7    Aquino, J.B.8    Matar, P.9    Mazzolini, G.10
  • 104
    • 84886944257 scopus 로고    scopus 로고
    • Chemoimmunotherapy as long-term maintenance therapy for cancer
    • Egilmez NK, Harden JL and Rowswell-Turner RB. Chemoimmunotherapy as long-term maintenance therapy for cancer. Oncoimmunology. 2012; 1:563-565.
    • (2012) Oncoimmunology , vol.1 , pp. 563-565
    • Egilmez, N.K.1    Harden, J.L.2    Rowswell-Turner, R.B.3
  • 105
    • 37349107870 scopus 로고    scopus 로고
    • The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat
    • Vogelbacher R, Wittmann S, Braun A, Daniel C and Hugo C. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat. Transplantation. 2007; 84:1492-1499.
    • (2007) Transplantation , vol.84 , pp. 1492-1499
    • Vogelbacher, R.1    Wittmann, S.2    Braun, A.3    Daniel, C.4    Hugo, C.5
  • 106
    • 17844385843 scopus 로고    scopus 로고
    • Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells
    • Minhajuddin M, Fazal F, Bijli KM, Amin MR and Rahman A. Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells. Journal of immunology. 2005; 174:5823-5829.
    • (2005) Journal of immunology , vol.174 , pp. 5823-5829
    • Minhajuddin, M.1    Fazal, F.2    Bijli, K.M.3    Amin, M.R.4    Rahman, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.